Gastroenterology

In a recent study, researchers sought to determine how inflammatory bowel disease affects the risk of influenza infection, and whether treatment with various IBD medications affected this risk.

There are currently no FDA-approved therapeutics for treating NAFLD, but many options are on the horizon. Steven Grinspoon, MD, discussed the options in this session.

In a new study, researchers aimed to determine the prevalence and predictors of symptoms of depression and anxiety in patients with IBD.

See what gastroenterology news your colleagues have been reading.

See what gastroenterology news your colleagues have been reading.

In a number of states, marijuana is legal for the treatment of inflammatory bowel disease. Recently, the authors of a new study aimed to gauge interest in medical and recreational marijuana use among IBD...

Researchers compared rates of clinical remission and endoscopic healing among patients with UC treated with vedolizumab.

Using data from a subset of 1087 infants from the CHILD cohort, the researchers investigated the effects of breastfeeding on gut microbiota profiles and the risk childhood overweight compared with formula...

Research presented at Digestive Disease Week 2018 aimed to determine the rates and identify predictors of serious adverse events with mono- and combo-therapy for Crohn disease and ulcerative colitis.